Cerus | Sustainability Performance
Develops technologies and products for blood safety and transfusion medicine.
1992
United States
201 - 500 employees
Biotechnology
$100M - 500M in revenue
N/A in profitability
Sustainability Ranking & Industry Benchmark
#9213
Overall#2064
in United States#196
in BiotechnologySustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and exclusionsB-corp & CDPFinancial Data
Business performanceCapital & innovationAnalyst projections
Market cap
Revenue
R&D intensity
Controversy level
Powered by illuminem
Market cap
Revenue
EBITDA
Operating margin
Revenue & EBITDA
$206.0MFY2025 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Revenue by region
Revenue by region %
BELGIUM
Europe, middle east and africa.
FRANCE
KUWAIT
North America
Other.
Other countries.
UNITED STATES
Powered by illuminem
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
R&D intensity
32.5%FY2025
R&D as % of revenue
R&D as % of revenue
Industry benchmark
Powered by illuminem
Return on invested capital
-10.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.2
▼ 4.6%
0.2
▼ 7.1%
0.2
▼ 10.8%
0.4
2030Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Not available
Recycling policy
Not available
Workplace health & safety policy
Available
50%
Independent Directors
6 out of 12 incl. management
Overall score
35
Environment
4
Social
39
Governance
63
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
CDP Scores
Climate Score
Not disclosed
Water Score
Not disclosed
A
A-
B
B-
C
C-
D
D-
